Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aptevo Therapeutics Inc. | SVP, CFO | Restricted Stock Unit | 1.58K | Mar 4, 2024 | Direct | ||
Aptevo Therapeutics Inc. | SVP, CFO | Common Stock | 576 | Aug 8, 2024 | Direct | ||
Aptevo Therapeutics Inc. | SVP, CFO | Restricted Stock Unit | 0 | Aug 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APVO | Aptevo Therapeutics Inc. | Aug 8, 2024 | 2 | $0 | 4 | Aug 9, 2024 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Jul 17, 2024 | 1 | $0 | 4 | Jul 19, 2024 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Mar 2, 2024 | 4 | $0 | 4 | Mar 5, 2024 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Jan 29, 2024 | 2 | $0 | 4 | Jan 30, 2024 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Aug 8, 2023 | 2 | $0 | 4 | Aug 10, 2023 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Mar 3, 2023 | 4 | $0 | 4 | Mar 7, 2023 | SVP, CFO |
APVO | Aptevo Therapeutics Inc. | Mar 3, 2023 | 0 | $0 | 3 | Mar 7, 2023 | SVP, CFO |